Grammar:		DataElement 5.0
Namespace:		oncocore
Description:	"SHR implementation of ASCO requirements."
Uses:  			shr.core, shr.base, shr.entity

CodeSystem:     SCT = http://snomed.info/sct
CodeSystem:     LNC = http://loinc.org
CodeSystem:		MTH = http://ncimeta.nci.nih.gov
CodeSystem:     UCUM = http://unitsofmeasure.org


Element:        CancerStageTiming 
Concept:        SCT#260869008 "Timing of stage"
Description:	"Indicates when staging was done, in terms of treatment landmarks."
Value:          CodeableConcept from CancerStageTimingVS if covered

Element:        CancerStageSuffix
Concept:	    TBD#TBD	    // TODO: Needs a new LOINC or SNOMED code + value set terms.  assign a local value set until we get something assigned.
Description: "A suffix used in conjuction with certain cancer stage categories, usually qualifying how the category value was determined."
Value:          CodeableConcept //from CancerStageSuffixVS  VS only includes terms applicable to BrCa.

Element:        CancerStagingSystem
Based on:       Method
Concept:        SCT#260713006 "Method of Staging (attribute)"
Value:          CodeableConcept from CancerStagingSystemVS if covered

Abstract Element:  CancerStagePanel
Based on:       HeadlessPanel
Description:    "A panel that contains cancer staging information. This abstract class is the parent of panels containing information related to clinical and pathologic staging."
0..1            CancerStageTiming
0..1            Method is type CancerStagingSystem
                Focus value is type ref(CancerDisorderPresent)

Abstract Element:  CancerStagePanelMember
Based on:       CodedNonLaboratoryObservation
Description:    "Abstract parent class for members of cancer staging panels. Cancer panel members must include a timing element and staging system, and focus on a cancer disorder. Specific realizations will have value sets specific to certain staging systems."
                Focus value is type ref(CancerDisorderPresent)
1..1            CancerStageTiming 
0..1            Method is type CancerStagingSystem
0..0		BodySite
0..0            ReferenceRange
0..0            Components
0..0            PanelMembers
0..0            Device

Abstract Element:   TNMStagePanelMember
Based on:       CancerStagePanelMember
Description:    "Abstract partent class for TNM staging panel members. Includes a stage suffix and TNM staging system."
0..1            CancerStageSuffix
                CancerStagingSystem from TNMTumorStagingSystemVS if covered


EntryElement:   TNMClinicalPrognosticStagePanel
Based on:       CancerStagePanel
Concept:        LNC#75620-5 "TNM clinical staging before treatment panel Cancer"
Description:    "A panel of TNM staging classifications, based on information obtained prior to neoadjuvant treatment and surgery, e.g. based on evidence such as physical examination, imaging, and/or biopsy."
                Code is LNC#75620-5 "TNM clinical staging before treatment panel Cancer"
                CancerStageTiming is SCT#385349001  "Clinical stage (observable entity)"   // timing is implicit in LOINC code, so this attribute could potentially could be eliminated
                Method from TNMTumorStagingSystemVS if covered
                PanelMembers.Observation
                    includes  0..1 TNMClinicalStageGroup
                    includes  0..1 TNMClinicalPrimaryTumorClassification
                    includes  0..1 TNMClinicalRegionalNodesClassification
                    includes  0..1 TNMClinicalDistantMetastasesClassification

        EntryElement:   TNMClinicalStageGroup
        Based on:       TNMStagePanelMember
        Concept:        LNC#21908-9 "Stage group.clinical Cancer"
        Description:    "The overall stage of the cancer, assessed using tests that are done before surgery. These include physical exams, imaging tests, laboratory tests (such as blood tests), and biopsies. (adapted from NCI Dictionary of Cancer Terms)."
                        Code is LNC#21908-9 "Stage group.clinical Cancer"
                        DataValue from http://loinc.org/vs/LL240-3 
                        CancerStageTiming is SCT#385349001   "Clinical stage (observable entity)"
                        0..0 CancerStageSuffix

        EntryElement:   TNMClinicalPrimaryTumorClassification
        Based on:		TNMStagePanelMember
        Concept:		LNC#21905-5 "Primary tumor.clinical [Class] Cancer"
        Description:    "Classification of the primary tumor, based on its size and extent, assessed prior to surgery, based on evidence such as physical examination, imaging, and/or biopsy."
                        Code is LNC#21905-5 "Primary tumor.clinical [Class] Cancer"
                        DataValue from http://loinc.org/vs/LL237-9 // normative answer list for LNC#21905-5
                        CancerStageTiming is SCT#385349001 "Clinical stage (observable entity)"

        EntryElement: 	TNMClinicalRegionalNodesClassification
        Based on:		TNMStagePanelMember
        Concept:		LNC#21906-3 "Regional lymph nodes.clinical [Class] Cancer"
        Description:    "Classification of the presence or absence of metastases in regional lymph nodes, assessed using tests that are done before surgery. These include physical exams, imaging tests, laboratory tests (such as blood tests), and biopsies. (adapted from NCI Dictionary of Cancer Terms)"
                        Code is LNC#21906-3 "Regional lymph nodes.clinical [Class] Cancer"
                        DataValue from http://loinc.org/vs/LL238-7 // normative answer list for LNC#21906-3
                        CancerStageTiming is SCT#385349001 "Clinical stage (observable entity)"

        EntryElement:   TNMClinicalDistantMetastasesClassification
        Based on:		TNMStagePanelMember
        Concept:		LNC#21907-1 "Distant metastases.clinical [Class] Cancer"
        Description:    "Classification of the presence or absense of metastases in remote anatomical locations, assessed using tests that are done before surgery. These include physical exams, imaging tests, laboratory tests (such as blood tests), and biopsies. (adapted from NCI Dictionary of Cancer Terms)" 
                        Code is LNC#21907-1 "Distant metastases.clinical [Class] Cancer"
                        DataValue from http://loinc.org/vs/LL239-5 // normative answer list for LNC#21907-1
                        CancerStageTiming is SCT#385349001 "Clinical stage (observable entity)"


EntryElement:   TNMPathologicPrognosticStagePanel
Based on:       CancerStagePanel
Concept:        LNC#75621-3 "TNM pathologic staging after surgery panel Cancer"
Description:    "A panel of staging information that is based on examination of tissue samples removed during surgery, in addition to physical examination and imaging and potentially, other prognostic factors."
                Code is LNC#75621-3 "TNM pathologic staging after surgery panel Cancer"
0..1            Method from TNMTumorStagingSystemVS if covered
                CancerStageTiming is SCT#405978005   "Pathologic stage (observable entity)"      
                PanelMembers.Observation
                    includes  0..1 TNMPathologicStageGroup
// TNM are not part of MCODE, but may be useful. TODO: How to we indicate that stage group is in MCODE, and T, N, M are not?
                    includes  0..1 TNMPathologicPrimaryTumorClassification
                    includes  0..1 TNMPathologicRegionalNodesClassification
                    includes  0..1 TNMPathologicDistantMetastasesClassification

        EntryElement:   TNMPathologicStageGroup
        Based on:       TNMStagePanelMember
        Concept:        LNC#21902-2  "Stage group.pathology Cancer"	 
        Description:    "The overall stage of the cancer, determined through pathologic analysis of a tumor specimen."
                        Code is LNC#21902-2  "Stage group.pathology Cancer"	
                        DataValue from http://loinc.org/vs/LL234-6 
                        CancerStageTiming is SCT#405978005   "Pathologic stage (observable entity)" 
                        0..0 CancerStageSuffix

        EntryElement:   TNMPathologicPrimaryTumorClassification
        Based on:		TNMStagePanelMember
        Concept:		LNC#21899-0 "Primary tumor.pathology Cancer"
        Description:    "Classification of the primary tumor, based on its size and extent, assessed through pathologic analysis of a tumor specimen."
                        Code is LNC#21899-0 "Primary tumor.pathology Cancer"
                        DataValue from http://loinc.org/vs/LL232-0 
                        CancerStageTiming is SCT#405978005 "Pathologic stage (observable entity)" 

        EntryElement: 	TNMPathologicRegionalNodesClassification
        Based on:		TNMStagePanelMember
        Concept:		LNC#21900-6 "Regional lymph nodes.pathology [Class] Cancer"
        Description:    "Classification of the presence or absence of metastases in regional lymph nodes, assessed through pathologic analysis of a specimen."
                        Code is LNC#21900-6 "Regional lymph nodes.pathology [Class] Cancer"
                        DataValue from http://loinc.org/vs/LL3136-0 
                        CancerStageTiming is SCT#405978005 "Pathologic stage (observable entity)" 

        EntryElement:   TNMPathologicDistantMetastasesClassification
        Based on:		TNMStagePanelMember
        Concept:		LNC#21901-4 "Distant metastases.pathology [Class] Cancer"
        Description:    "Classification of the presence or absense of metastases in remote anatomical locations, assessed through pathologic analysis of a specimen."
                        Code is LNC#21901-4 "Distant metastases.pathology [Class] Cancer"
                        DataValue from http://loinc.org/vs/LL3137-8 
                        CancerStageTiming is SCT#405978005 "Pathologic stage (observable entity)"


/* Possible generalization of BrCa classes, gets pretty cumbersome because the additional elements are under each TNM category, not directly on the panel itself.
EntryElement:   TNMClinicalPrognosticStagePanelWithEvidence
Based on:       TNMClinicalPrimaryTumorClassification
// Concept inherited
Description:    "A panel of TNM staging classifications, based on information obtained prior to neoadjuvant treatment and surgery, e.g. based on evidence such as physical examination, imaging, and/or biopsy. The panel also includes supporting findings critical to the assignment of the T, N and M clinical classifications, such as the size of the primary tumor for the T category."
                PanelMembers.Observation.TNMClinicalPrimaryTumorClassification is type TNMClinicalPrimaryTumorClassificationWithEvidence
                PanelMembers.Observation.TNMClinicalRegionalNodesClassification is type TNMClinicalRegionalNodesClassificationWithEvidence


EntryElement:   TNMClinicalPrimaryTumorClassificationWithEvidence
Based on:       TNMClinicalPrimaryTumorClassification
// Concept inherited
Description:    "Classification of the primary tumor, based on its size and extent, assessed prior to surgery. Also includes supporting evidence used to derive the pathologic T classification."
                PanelMembers.Observation
                    includes 0..1 TumorDimensionsPrimaryTumor //TODO: may need to distinguish dimensions based on pre-surgical vs. surgical findings outside of staging


EntryElement:   TNMClinicalRegionalNodesClassificationWithEvidence
Based on:       TNMClinicalRegionalNodesClassification
// Concept inherited
Description:   "Classification of the presence or absence of metastases in regional lymph nodes, assessed using tests that are done before surgery. Also includes supporting evidence used to derive the N classification."
                PanelMembers.Observation
                    // includes 0..* ClinicalLymphNodeInvolvement TODO: Generalize BreastClinicalNodeInvolvement to ClinicalNodeInvolvement


EntryElement:   TNMPathologicPrognosticStagePanelWithEvidence
Based on:       TNMPathologicPrognosticStagePanel
// Concept inherited
Description:    "A panel of staging information that is based on examination of tissue samples removed during surgery, in addition to physical examination and imaging and potentially, other prognostic factors. The panel also includes supporting findings critical to the assignment of the T, N and M pathologic classifications, such as the size of the primary tumor for the T category."
                PanelMembers.Observation.TNMPathologicPrimaryTumorClassification is type TNMPathologicPrimaryTumorClassificationWithEvidence
                PanelMembers.Observation.TNMPathologicRegionalNodesClassification is type TNMPathologicRegionalNodesClassificationWithEvidence


EntryElement:   TNMPathologicPrimaryTumorClassificationWithEvidence
Based on:       TNMPathologicPrimaryTumorClassification
// Concept inherited
Description:    "Classification of the primary tumor, based on its size and extent, assessed through pathologic analysis of a tumor specimen. Also includes supporting evidence used to derive the pathologic T classification."
                PanelMembers.Observation
                    includes 0..1 TumorDimensionsPrimaryTumor //TODO: may need to distinguish dimensions based on pre-surgical vs. surgical findings outside of staging


EntryElement:   TNMPathologicRegionalNodesClassificationWithEvidence
Based on:       TNMPathologicRegionalNodesClassificationWithEvidence
// Concept inherited
Description:    "Classification of the presence or absence of metastases in regional lymph nodes, assessed through pathologic analysis of a specimen. Also includes supporting evidence used to derive the pathologic N classification."
                PanelMembers.Observation
                    // includes 0..* PathologicLymphNodeInvolvement TODO: Generalize BreastPathologicNodeInvolvement to PathologicNodeInvolvement
*/

//TODO: EntryElement:   TNMPostNeoadjuvantTherapyStagePanel
//TODO: EntryElement:   TNMRecurrenceStagePanel
//TODO: EntryElement:   TNMAutopsyStagePanel
